LLY

1,004.99

+0.97%↑

JNJ

244.63

+0.89%↑

ABBV

228.21

+1.22%↑

NVS

162.46

+1%↑

AZN

196.85

+2.12%↑

LLY

1,004.99

+0.97%↑

JNJ

244.63

+0.89%↑

ABBV

228.21

+1.22%↑

NVS

162.46

+1%↑

AZN

196.85

+2.12%↑

LLY

1,004.99

+0.97%↑

JNJ

244.63

+0.89%↑

ABBV

228.21

+1.22%↑

NVS

162.46

+1%↑

AZN

196.85

+2.12%↑

LLY

1,004.99

+0.97%↑

JNJ

244.63

+0.89%↑

ABBV

228.21

+1.22%↑

NVS

162.46

+1%↑

AZN

196.85

+2.12%↑

LLY

1,004.99

+0.97%↑

JNJ

244.63

+0.89%↑

ABBV

228.21

+1.22%↑

NVS

162.46

+1%↑

AZN

196.85

+2.12%↑

Inicio・Lista de Acciones・Ascendis Pharma A-S ADR

Ascendis Pharma A-S ADR

Abierto

SectorSalud

241 1.54

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

236.83

Máximo

244.71

Métricas clave
By Trading Economics
Ingresos	28M -33M
Ventas	32M 245M
Margen de beneficio	-13.56
Empleados	1,189
EBITDA	68M 15M

Recomendaciones
By TipRanks
Recomendaciones	Compra Fuerte
Estimación a 12 meses	+21.89% upside

Dividendos
By Dow Jones
Próximas Ganancias	30 abr 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización de Mercado	1.3B 15B
Apertura anterior	239.46
Cierre anterior	241

Noticias sobre sentimiento de mercado

By Acuity

54%

46%

268 / 351 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Very Strong Bearish Evidence

157.66 / 167.29 Soporte y Resistencia

Ascendis Pharma A-S ADR Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

9 mar 2026, 18:13 UTC

Adquisiciones, fusiones, absorciones

Shell to Sell Jiffy Lube to Monomoy in $1.3 Billion Deal -- Update

9 mar 2026, 17:20 UTC

Noticias de Eventos Importantes

U.S. Ag Industry Calls for Government Intervention on Fertilizer Prices

9 mar 2026, 17:15 UTC

Adquisiciones, fusiones, absorciones

Shell to Sell Jiffy Lube and Premium Velocity to Monomoy for $1.3 Billion

10 mar 2026, 00:00 UTC

Noticias de Eventos Importantes

Why Iranian Regime Change Would Transform Global Energy Markets -- WSJ

9 mar 2026, 23:52 UTC

Charlas de Mercado

Gold Steady; May Be Supported by Dollar's Weakness -- Market Talk

9 mar 2026, 23:50 UTC

Charlas de Mercado

Nikkei May Rise as Fears About Higher Energy Prices Ease -- Market Talk

9 mar 2026, 23:50 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

9 mar 2026, 23:46 UTC

Charlas de Mercado

Noticias de Eventos Importantes

Correction to Crude Prices Market Talk on March 9

9 mar 2026, 23:42 UTC

Charlas de Mercado

Noticias de Eventos Importantes

Oil Futures Fall Amid Developments That Could Help Supply -- Market Talk

9 mar 2026, 23:08 UTC

Noticias de Eventos Importantes

Front-Month WTI Futures Drop 7.9% to $87.29/bbl, ICE Data Show

9 mar 2026, 23:07 UTC

Noticias de Eventos Importantes

Front-Month WTI Futures Fall After Trump Says Iran War Will Be Over 'Very Soon'

9 mar 2026, 21:29 UTC

Adquisiciones, fusiones, absorciones

Fortescue Now Fully Owns Peru's Canariaco Copper Project

9 mar 2026, 21:28 UTC

Adquisiciones, fusiones, absorciones

Fortescue Completes Acquisition of Remaining Alta Copper Shares

9 mar 2026, 20:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

9 mar 2026, 20:50 UTC

Charlas de Mercado

Financial Services Roundup: Market Talk

9 mar 2026, 20:47 UTC

Noticias de Eventos Importantes

The 24 Hours When Oil Markets Went Wild -- WSJ

9 mar 2026, 20:33 UTC

Noticias de Eventos Importantes

Stock Market Today: Oil Slips, Stocks Bounce on Trump War-Progress Comments Headline -- WSJ

9 mar 2026, 20:14 UTC

Charlas de Mercado

Noticias de Eventos Importantes

Oil Moves Lower As Trump Says War Could End Soon -- Market Talk

9 mar 2026, 19:33 UTC

Noticias de Eventos Importantes

High Oil Prices Could Crimp Convenience Store Margins -- Barrons.com

9 mar 2026, 19:17 UTC

Charlas de Mercado

Noticias de Eventos Importantes

Prospect of Added Supply From Oil Reserves Ease Inflation Fears -- Market Talk

9 mar 2026, 19:14 UTC

Charlas de Mercado

Oil Settles Off Highs As G7 Discusses Tapping Reserves -- Market Talk

9 mar 2026, 19:00 UTC

Charlas de Mercado

U.S. Natural Gas Futures Settle Lower -- Market Talk

9 mar 2026, 18:23 UTC

Charlas de Mercado

Noticias de Eventos Importantes

BofA Drops Canada Rate-Cut Call on Higher Oil Prices -- Market Talk

9 mar 2026, 17:58 UTC

Adquisiciones, fusiones, absorciones

Shell to Sell Jiffy Lube to Monomoy in $1.3B Deal -- Update

9 mar 2026, 17:57 UTC

Adquisiciones, fusiones, absorciones

Activist Investors Target Food Companies as Growth Slows. Lamb Weston Is the Latest. -- Barrons.com

9 mar 2026, 17:41 UTC

Noticias de Eventos Importantes

U.S. and Western Allies Turn to Reserves to Counteract Gulf Oil Crisis -- WSJ

9 mar 2026, 17:41 UTC

Charlas de Mercado

Noticias de Eventos Importantes

Reports of Saudi Production Shut-Ins Keep Bid in Crude -- Market Talk

9 mar 2026, 17:08 UTC

Charlas de Mercado

Canada Rate Outlook Shifts From Long Pause to Late 2026 Hike -- Market Talk

9 mar 2026, 17:04 UTC

Charlas de Mercado

Noticias de Eventos Importantes

Global Forex and Fixed Income Roundup: Market Talk

9 mar 2026, 17:04 UTC

Charlas de Mercado

Noticias de Eventos Importantes

Treasury Yields, Dollar Off Highs as G7 Tackles Oil Shock -- Market Talk

Comparación entre iguales

Cambio de precio

Ascendis Pharma A-S ADR Esperado

Precio Objetivo

By TipRanks

21.89% repunte

Estimación a 12 meses

Media 293.33 USD 21.89%

Máximo 342 USD

Mínimo 255 USD

De acuerdo con 12 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Ascendis Pharma A-S ADR Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

12 ratings

Comprar

Mantener

Vender

De acuerdo con 12 analistas que ofrecen calificaciones bursátiles a para Ascendis Pharma A-S ADR Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

157.66 / 167.29Soporte y Resistencia

Recent bearish events outweigh bullish events.

Bullish events outweigh bearish events.

All events are bullish.

Sentimiento

By Acuity

268 / 351 Clasificación en Salud

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Ascendis Pharma A-S ADR

Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapies for unmet medical needs. It offers SKYTROFA for treating patients with growth hormone deficiency (GHD). The company is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark.